The venous excess ultrasound score (VExUS) is a promising method to assess venous congestion in adults, but evidence in children is scarce. This study aimed to evaluate the feasibility, reproducibility, and clinical usefulness of VExUS in pediatric patients. We also explored whether portal venous Doppler (PVD) alone could serve as a faster alternative and assessed the role of inferior vena cava (IVC) measurements. In this prospective single-center study, 35 pediatric patients were enrolled between 2022 and 2024. Associations between clinical variables and VExUS grades at admission (VExUS-0), 24 h (VExUS-24 h), and 48 h (VExUS-48 h), as well as PVD at corresponding time points, were analyzed. The relationship between IVC diameter and VExUS was also evaluated. VExUS demonstrated perfect reproducibility (κ coefficient and intraclass correlation coefficient = 1). Patients with VExUS-0 or VExUS-24 h grades 2–3 had longer aortic cross-clamp times (p = 0.03; 0.04) and higher vasoactive–inotropic scores (p = 0.01) than those graded 0–1. A higher incidence of acute kidney injury was observed in VExUS-24 h grades 2–3 (p = 0.04). Similar associations were found with PVD. Most patients with VExUS grades 2–3 had non-dilated IVCs according to pediatric reference values.Conclusion: VExUS is a feasible, reproducible, and clinically relevant bedside tool for detecting venous congestion in children. Its association with morbidity markers suggests prognostic potential, with optimal performance 24 h after PICU admission. PVD may provide comparable information in less time, while IVC diameter appears unreliable for this purpose.<Table Float="No" ID="Taba"> <tgroup cols="2"> <colspec align="left" colname="c1" colnum="1" /> <colspec align="left" colname="c2" colnum="2" /> <tbody> <row> <entry nameend="c2" namest="c1"> What is Known: • VExUS enables bedside assessment of venous congestion and is associated with adverse outcomes in adults, particularly after cardiac surgery. • However, pediatric evidence is limited, and its clinical applicability remains uncertain. </entry> </row> <row> <entry nameend="c2" namest="c1"> What is New: • This study shows that VExUS is feasible, reproducible, and associated with morbidity after pediatric cardiac surgery, with the highest prognostic value at 24h. • Portal Doppler may provide comparable performance, whereas IVC diameter is is not a reliable marker of venous congestion in this population. </entry> </row> </tbody> </tgroup> </Table>

Feasibility, reproducibility, clinical value of the VExUS score after pediatric cardiac surgery and main differences from adults’ perspective

期刊论文
出版模式：

开放获取
发表日期：

2026年5月8日

查看全文

Daniel Palanca Arias,
Marcos Clavero Adell,
Aida Lorente López,
Ariadna Ayerza Casas,
Victoria Estabén Boldova,
Irene Gil Hernández,
Almudena Alonso Ojembarrena

摘要

The venous excess ultrasound score (VExUS) is a promising method to assess venous congestion in adults, but evidence in children is scarce. This study aimed to evaluate the feasibility, reproducibility, and clinical usefulness of VExUS in pediatric patients. We also explored whether portal venous Doppler (PVD) alone could serve as a faster alternative and assessed the role of inferior vena cava (IVC) measurements. In this prospective single-center study, 35 pediatric patients were enrolled between 2022 and 2024. Associations between clinical variables and VExUS grades at admission (VExUS-0), 24 h (VExUS-24 h), and 48 h (VExUS-48 h), as well as PVD at corresponding time points, were analyzed. The relationship between IVC diameter and VExUS was also evaluated. VExUS demonstrated perfect reproducibility (κ coefficient and intraclass correlation coefficient = 1). Patients with VExUS-0 or VExUS-24 h grades 2–3 had longer aortic cross-clamp times (p = 0.03; 0.04) and higher vasoactive–inotropic scores (p = 0.01) than those graded 0–1. A higher incidence of acute kidney injury was observed in VExUS-24 h grades 2–3 (p = 0.04). Similar associations were found with PVD. Most patients with VExUS grades 2–3 had non-dilated IVCs according to pediatric reference values.

Conclusion: VExUS is a feasible, reproducible, and clinically relevant bedside tool for detecting venous congestion in children. Its association with morbidity markers suggests prognostic potential, with optimal performance 24 h after PICU admission. PVD may provide comparable information in less time, while IVC diameter appears unreliable for this purpose.

What is Known:

• VExUS enables bedside assessment of venous congestion and is associated with adverse outcomes in adults, particularly after cardiac surgery.

• However, pediatric evidence is limited, and its clinical applicability remains uncertain.

What is New:

• This study shows that VExUS is feasible, reproducible, and associated with morbidity after pediatric cardiac surgery, with the highest prognostic value at 24h.

• Portal Doppler may provide comparable performance, whereas IVC diameter is is not a reliable marker of venous congestion in this population.